Tech vendor Reveleer and policy analytics firm Mathematica released their 2025 State of Technology in Value-Based Care report, the findings of which show that AI adoption in healthcare is widespread—but integration is spotty. 

FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.

It's another big victory for Abbott's bioresorbable stent for BTK PAD. 

When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life. 

"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry.  "This is not a trial; this is real-world experience."

The 22-year-old patient was undergoing a computed tomography exam with contrast due to her history of kidney stones.

The Class I recall includes more than 26,000 vascular stents from Boston Scientific. These devices have been linked to a risk of potential resistance when the stent delivery system is being withdrawn. 

Societies representing chest physicians, orthopedic foot and ankle specialists, thoracic and plastic surgeons, and gynecologic oncologists are joining ACR in the effort. 

Radiation oncologists and other specialists wore the devices for six months at two pilot institutions, with promising initial results. 

Founded in 2021 as a spinoff of the Cleveland Clinic, its platform leverages continuous 3D ultrasound and AI-generated surgical plans to guide robotic-assisted procedures.